Latest Posts
About This Stock
More About This Stock
Read
Read
Read
ABBV: A Safe 4.7% Yield In Biopharma
Article By:
Marc Lichtenfeld
Wednesday, January 20, 2021 7:19 PM EST
Even with the slightly lower free cash flow total in 2019, AbbVie had more than enough to afford the $6.4 billion in dividends that it paid.
5 Top Healthcare Stocks For 2021
Article By:
StockNews
Monday, January 18, 2021 10:38 AM EST
One market truism is that healthcare tends to outperform during Democratic administrations, while defense companies tend to do better under Republicans. Therefore, investors should consider healthcare stocks.
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By:
Rod Raynovich
Thursday, January 14, 2021 5:42 AM EST
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
5 Leading Healthcare Stocks Surging On Pent-up Demand
Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.
5 Leading Healthcare Stocks Surging On Pent-up Demand
Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE
Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.
AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
How much debt does $ABBV have?
AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
$ABBV certainly sounds like a great buy.
AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).